Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > INSIDER BUY - "Chairman steps up"
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by specul8toron Mar 05, 2016 11:26am
131 Views
Post# 24625791

RE:RE:RE:RE:RE:RE:INSIDER BUY - "Chairman steps up"

RE:RE:RE:RE:RE:RE:INSIDER BUY - "Chairman steps up"vega509 you may be right.The purchase could simply be done to try and show some kind of support to the stock.We will certainly know by this time next week if we are still at a dime....or less..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities